In vitro transfer of cellular immunity to synthetic peptides of HIV-1 to human lymphocytes with exogenous RNA

Sales, Valéria S. F; Sawan, Fahim M; Watanabe, Maria A. E; Silva, João S; Voltarelli, Julio C; De Lucca, Fernando L.
Mem. Inst. Oswaldo Cruz ; 91(3): 349-350, May-Jun. 1996.
Artículo en Inglés | LILACS | ID: lil-319864

Documentos relacionados

  1. Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys.
  2. Characterization and epitope mapping of a panel of monoclonal antibodies against HIV-1 matrix protein.
  3. Tailored immunogens for rationally designed antibody-based HIV-1 vaccines.
  4. The vaccinologist's "dirty little secret": a better understanding of structure-function relationships of viral immunogens might advance rational HIV vaccine design.
  5. Immune screening identifies novel T cell targets encoded by antisense reading frames of HIV-1.
  6. Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics.
  7. Structure of the membrane proximal external region of HIV-1 envelope glycoprotein.
  8. Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer Antigens.
  9. HIV p17 enhances T cell proliferation by suppressing autophagy through the p17-OLA1-GSK3ß axis under nutrient starvation.
  10. Antigen-processing and presentation pathways select antigenic HIV peptides in the fight against viral evolution.